Scientists hunt clues in blood and breath as cancer outsmarts drug
NCT ID NCT04653740
Summary
This study aims to understand why some advanced breast cancers become resistant to the drug palbociclib. Researchers will follow 25 women with hormone-positive breast cancer, collecting tumor samples and breath/body fluid samples before treatment and when the cancer progresses. By analyzing molecular changes over time, they hope to identify patterns that could help predict or overcome treatment resistance in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, France, 59020, France
Conditions
Explore the condition pages connected to this study.